In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation
Case Number:
2:17-md-02785
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Fredrikson & Byron
- Burns Charest
- Law Offices of Ursula Taylor
- Foulston Siefkin
- Matthew G. Miller PC
- Gustafson Gluek
- McCune Law
- Goodwin Procter
- Butler Prather
- Parker Waichman
- Siegfried & Jensen
- Bradford & Wilson
- Spragens Law
- Robbins Geller
- Hogan Lovells
- DLA Piper
- Wilson Sonsini
- Reed Smith
- Lockridge Grindal
- DiCello Levitt
- Weil Gotshal
- Pritzker Levine
- Lathrop GPM
- Willkie Farr
- Blood Hurst
- Berkowitz Oliver
- Boies Schiller
- Alexander Appellate Law
- Joseph Saveri Law Firm
- Williams & Connolly
- Saiber LLC
- Robins Kaplan
- Foley & Lardner
- Barton & Burrows
- Kaufman & Canoles
- Spencer Fane
- Goldman Scarlato
- Robbins Russell
- Lightfoot Franklin
- Roberts Law Firm US
- Whiteford Taylor
- Horn Aylward
- Dollar Burns
- Holland & Knight
- King & Spalding
- Lanier Law Firm
- Gibbs Mura
- Kopelowitz Ostrow
- Squitieri & Fearon
- Perkins Coie
- Hagens Berman
- White & Case
- Shook Hardy
- Kramer Levin
- Hinkle Law Firm
- Sidley Austin
- Carella Byrne
- Strategic Health Law
- Keller Rohrback
- Gibson Dunn
- Groom Law Group
- Nussbaum Law Group
- Barnow and Associates
- Marion's Inn
- Pallas Partners
- Bush Seyferth
- Wagstaff & Cartmell
- Mehri & Skalet
- Wallace Saunders
- Lowey Dannenberg
- Steven Williams Law
- Levi & Korsinsky
- Gibbons PC
- Beasley Allen
- Berman Tabacco
- Ali & Lockwood
- Clark Hill
- GM Law PC
- Baron & Budd
- Orrick Herrington
- HSF Kramer
- Mayer Brown
Companies
- Amerigroup Corp.
- Change Healthcare Inc.
- MedImpact Healthcare Systems Inc.
- Humana Inc.
- Blue Cross Blue Shield Association
- Meridian Medical Technologies Inc.
- Coventry Health Care Inc.
- Express Scripts Holding Co.
- CVS Health Corp.
- The Segal Co. Inc.
- UnitedHealth Group Inc.
- Viatris Inc.
- Aetna Inc.
- OptumRx Inc.
- Centene Corp.
- King Pharmaceuticals Inc.
- Optum Inc.
- Sanofi
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
- 
						August 20, 2018
						Mylan, Pfizer Barely Put Dent In EpiPen Antitrust MDLMylan NV and Pfizer Inc. on Monday largely failed to scale down multidistrict litigation over sky-high prices for emergency allergy treatment EpiPen, as a Kansas federal judge mostly refused to throw out wide-ranging consumer claims of anti-competitive shenanigans. 
- 
						June 12, 2018
						Humana Ordered To Turn Over Docs In EpiPen Antitrust MDLA Kansas federal judge on Monday ordered Humana Inc. to hand over within three weeks documents related to a multidistrict litigation accusing drugmaker Mylan NV of antitrust violations related to a surge in the price of its allergy treatment device, the EpiPen. 
- ← Previous
- 1
- 2
- 3
- 4
- 5
- Next →